{"disease":{"id":"early-stage-non-small-cell-lung-cancer","name":"early stage non small cell lung cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06737107","title":"Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":472,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT07167459","title":"Personalized SBRT in Early-Stage Peripheral NSCLC","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":251,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT06430866","title":"Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":163,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT07008742","title":"Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Royal Marsden NHS Foundation Trust","has_results":false},{"nct_id":"NCT03925103","title":"Assessment of Ergonomics in 3D vs 2D Thoracoscopic Lobectomy","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"University of Rome Tor Vergata","has_results":false},{"nct_id":"NCT07498439","title":"TILs Therapy for Multiple Primary Early-Stage NSCLC","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT03916367","title":"CT-guided Radioactive I-125 Seeds Implantation for Early Stage Lung Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT04530227","title":"Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT05785845","title":"Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":17,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03546829","title":"Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":false},{"nct_id":"NCT03050554","title":"SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Andrew Sharabi","has_results":true}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}